Skip to main content
Erschienen in: Die Anaesthesiologie 10/2021

29.07.2021 | Gastrointestinale Blutung | Journal Club

Fokus allgemeine Intensivmedizin. Intensivmedizinische Studien aus 2020/2021

verfasst von: M. Dietrich, C. Beynon, M. O. Fiedler, M. Bernhard, P. Kümpers, A. Hecker, C. Jungk, C. Nusshag, D. Michalski, T. Brenner, Prof. Dr. med. M. A. Weigand, C. J. Reuß

Erschienen in: Die Anaesthesiologie | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten
Literatur
2.
Zurück zum Zitat Marik PE et al (2017) Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 151(6):1229–1238CrossRef Marik PE et al (2017) Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 151(6):1229–1238CrossRef
3.
Zurück zum Zitat Fowler AA 3rd et al (2019) Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA 322(13):1261–1270CrossRef Fowler AA 3rd et al (2019) Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA 322(13):1261–1270CrossRef
4.
Zurück zum Zitat Fujii T et al (2020) Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA 323(5):423–431CrossRef Fujii T et al (2020) Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA 323(5):423–431CrossRef
5.
Zurück zum Zitat Colliou E et al (2017) Oxalate nephropathy following vitamin C intake within intensive care unit. Clin Nephrol 88(12):354–358CrossRef Colliou E et al (2017) Oxalate nephropathy following vitamin C intake within intensive care unit. Clin Nephrol 88(12):354–358CrossRef
6.
Zurück zum Zitat McHugh GJ, Graber ML, Freebairn RC (2008) Fatal vitamin C‑associated acute renal failure. Anaesth Intensive Care 36(4):585–588CrossRef McHugh GJ, Graber ML, Freebairn RC (2008) Fatal vitamin C‑associated acute renal failure. Anaesth Intensive Care 36(4):585–588CrossRef
7.
Zurück zum Zitat Moskowitz A et al (2020) Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA 324(7):642–650CrossRef Moskowitz A et al (2020) Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA 324(7):642–650CrossRef
8.
Zurück zum Zitat Hwang SY et al (2020) Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study. Intensive Care Med 46(11):2015–2025CrossRef Hwang SY et al (2020) Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study. Intensive Care Med 46(11):2015–2025CrossRef
9.
Zurück zum Zitat Iglesias J et al (2020) Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: the ORANGES trial. Chest 158(1):164–173CrossRef Iglesias J et al (2020) Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: the ORANGES trial. Chest 158(1):164–173CrossRef
10.
Zurück zum Zitat Sevransky JE et al (2021) Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA 325(8):742–750CrossRef Sevransky JE et al (2021) Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA 325(8):742–750CrossRef
11.
Zurück zum Zitat Hasegawa D et al (2021) Effect of ultrashort-acting beta-blockers on mortality in patients with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials. Chest 159(6):2289–2230CrossRef Hasegawa D et al (2021) Effect of ultrashort-acting beta-blockers on mortality in patients with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials. Chest 159(6):2289–2230CrossRef
12.
Zurück zum Zitat Singer M et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801–810CrossRef Singer M et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801–810CrossRef
13.
Zurück zum Zitat SepNet Critical Care Trials Group (2016) Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med 42(12):1980–1989CrossRef SepNet Critical Care Trials Group (2016) Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med 42(12):1980–1989CrossRef
14.
Zurück zum Zitat Brechot N et al (2020) Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet 396(10250):545–552CrossRef Brechot N et al (2020) Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet 396(10250):545–552CrossRef
15.
Zurück zum Zitat Taniguchi T et al (2004) Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 32(6):1322–1326CrossRef Taniguchi T et al (2004) Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 32(6):1322–1326CrossRef
16.
Zurück zum Zitat Li Y et al (2015) Effect of dexmedetomidine on early postoperative cognitive dysfunction and peri-operative inflammation in elderly patients undergoing laparoscopic cholecystectomy. Exp Ther Med 10(5):1635–1642CrossRef Li Y et al (2015) Effect of dexmedetomidine on early postoperative cognitive dysfunction and peri-operative inflammation in elderly patients undergoing laparoscopic cholecystectomy. Exp Ther Med 10(5):1635–1642CrossRef
17.
Zurück zum Zitat Ohta Y et al (2020) Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: a sub-analysis of a multicenter randomized clinical trial. Crit Care 24(1):493CrossRef Ohta Y et al (2020) Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: a sub-analysis of a multicenter randomized clinical trial. Crit Care 24(1):493CrossRef
18.
Zurück zum Zitat Chen P et al (2020) Effect of dexmedetomidine on duration of mechanical ventilation in septic patients: a systematic review and meta-analysis. BMC Pulm Med 20(1):42CrossRef Chen P et al (2020) Effect of dexmedetomidine on duration of mechanical ventilation in septic patients: a systematic review and meta-analysis. BMC Pulm Med 20(1):42CrossRef
19.
Zurück zum Zitat WOMAN Trial Collaborators (2017) Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389(10084):2105–2116CrossRef WOMAN Trial Collaborators (2017) Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389(10084):2105–2116CrossRef
20.
Zurück zum Zitat CRASH‑2 Trial Collaborators, et al. (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376(9734):23–32CrossRef CRASH‑2 Trial Collaborators, et al. (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376(9734):23–32CrossRef
21.
Zurück zum Zitat CRASH‑3 Trial Collaborators (2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394(10210):1713–1723CrossRef CRASH‑3 Trial Collaborators (2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394(10210):1713–1723CrossRef
22.
Zurück zum Zitat HALT-IT Trial Collaborators (2020) Effects of a high-dose 24‑h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 395(10241):1927–1936CrossRef HALT-IT Trial Collaborators (2020) Effects of a high-dose 24‑h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 395(10241):1927–1936CrossRef
23.
Zurück zum Zitat Gluud LL, Klingenberg SL, Langholz E (2012) Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev 1:CD6640PubMed Gluud LL, Klingenberg SL, Langholz E (2012) Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev 1:CD6640PubMed
24.
Zurück zum Zitat Lau JYW, Yu Y, Chan FKL (2020) Timing of endoscopy for acute upper gastrointestinal bleeding. Reply. N Engl J Med 383(4):e19CrossRef Lau JYW, Yu Y, Chan FKL (2020) Timing of endoscopy for acute upper gastrointestinal bleeding. Reply. N Engl J Med 383(4):e19CrossRef
Metadaten
Titel
Fokus allgemeine Intensivmedizin. Intensivmedizinische Studien aus 2020/2021
verfasst von
M. Dietrich
C. Beynon
M. O. Fiedler
M. Bernhard
P. Kümpers
A. Hecker
C. Jungk
C. Nusshag
D. Michalski
T. Brenner
Prof. Dr. med. M. A. Weigand
C. J. Reuß
Publikationsdatum
29.07.2021
Verlag
Springer Medizin
Erschienen in
Die Anaesthesiologie / Ausgabe 10/2021
Print ISSN: 2731-6858
Elektronische ISSN: 2731-6866
DOI
https://doi.org/10.1007/s00101-021-00976-x

Weitere Artikel der Ausgabe 10/2021

Die Anaesthesiologie 10/2021 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.